Visitez le Centre des normes sur InfoCentral pour un aperçu des points saillants de la plus récente édition canadie… https://t.co/ppS7PEvu3Z
A generic SNOMED-CT concept has been created for the COVID-19 non-replicating vector vaccine group (the parent concept in which the AstraZeneca, COVISHIELD and Janssen vaccines fall under):
- ConceptID: 29061000087103
- FSN: Vaccine product containing only non-replicating viral vector encoding protein of Severe acute respiratory syndrome coronavirus 2 (medicinal product)
- PT: COVID-19 non-replicating vector vaccine
- Syn: Vaccine product containing only non-replicating viral vector encoding protein of Severe acute respiratory syndrome coronavirus 2 | COVID-19 non-replicant vector vaccine
The concept is in scope for the next CVC release. It has been created in the CA Edition and is in scope for the March CA Edition publication. It will also be sent to SI for candidate in the July 2021 INT release. The full RFC can be viewed here: https://informs.infoway-inforoute.ca/browse/SCT-11026?filter=-2 (note that you must register for an InfoCentral account and request access to Informs).
Please don't hesitate to let me know if you have any questions.
All the best,
L'administrateur a désactivé l'accès en écriture pour le public.